Market Closed -
Hong Kong S.E.
01:38:06 30/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
24.45
HKD
|
+2.52%
|
|
+2.73%
|
+16.99%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
16,708
|
8,413
|
4,747
|
6,088
|
7,056
|
-
|
-
|
Enterprise Value (EV)
1 |
12,248
|
5,924
|
4,367
|
6,088
|
6,369
|
6,299
|
7,080
|
P/E ratio
|
-0.86
x
|
-8.24
x
|
-18.5
x
|
-
|
-11.1
x
|
-46
x
|
441
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
1,55,805
x
|
371
x
|
48.3
x
|
10.5
x
|
4.64
x
|
2.92
x
|
EV / Revenue
|
-
|
1,09,710
x
|
341
x
|
48.3
x
|
9.46
x
|
4.14
x
|
2.93
x
|
EV / EBITDA
|
-18.3
x
|
-5.95
x
|
-20.4
x
|
-
|
-14.1
x
|
112
x
|
19.3
x
|
EV / FCF
|
-12.8
x
|
-7.32
x
|
-
|
-
|
-5.25
x
|
-19.9
x
|
-30.9
x
|
FCF Yield
|
-7.81%
|
-13.7%
|
-
|
-
|
-19.1%
|
-5.03%
|
-3.23%
|
Price to Book
|
0.71
x
|
1.41
x
|
0.81
x
|
-
|
1.8
x
|
1.84
x
|
-
|
Nbr of stocks (in thousands)
|
2,93,222
|
2,96,715
|
3,09,246
|
3,20,493
|
3,19,835
|
-
|
-
|
Reference price
2 |
56.98
|
28.36
|
15.35
|
19.00
|
22.06
|
22.06
|
22.06
|
Announcement Date
|
22/03/21
|
28/03/22
|
30/03/23
|
27/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
0.054
|
12.8
|
125.9
|
673.3
|
1,522
|
2,418
|
EBITDA
1 |
-
|
-668.1
|
-995.2
|
-214
|
-
|
-450.2
|
56.3
|
366.8
|
EBIT
1 |
-
|
-688.5
|
-1,054
|
-256.8
|
-932.7
|
-649.4
|
-155.5
|
-96.4
|
Operating Margin
|
-
|
-
|
-19,52,274.07%
|
-2,006.25%
|
-740.67%
|
-96.44%
|
-10.22%
|
-3.99%
|
Earnings before Tax (EBT)
1 |
-
|
-5,658
|
-1,009
|
-247.3
|
-844.5
|
-623.5
|
-138.2
|
18.82
|
Net income
1 |
-214.5
|
-5,658
|
-1,009
|
-247.3
|
-844.5
|
-623.5
|
-150.6
|
16
|
Net margin
|
-
|
-
|
-18,67,962.96%
|
-1,932.03%
|
-670.57%
|
-92.6%
|
-9.89%
|
0.66%
|
EPS
2 |
-41.04
|
-66.29
|
-3.440
|
-0.8300
|
-
|
-1.986
|
-0.4791
|
0.0500
|
Free Cash Flow
1 |
-
|
-956.4
|
-808.8
|
-
|
-
|
-1,214
|
-317
|
-229
|
FCF margin
|
-
|
-
|
-14,97,844.44%
|
-
|
-
|
-180.31%
|
-20.83%
|
-9.47%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/09/20
|
22/03/21
|
28/03/22
|
30/03/23
|
27/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
-
|
-
|
0.054
|
1.044
|
11.76
|
8.9
|
252.7
|
459.7
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-406.3
|
-653.9
|
-639.6
|
382.8
|
-
|
-340.1
|
-295.1
|
Operating Margin
|
-
|
-
|
-12,10,977.78%
|
-61,269.16%
|
3,256.63%
|
-
|
-134.57%
|
-64.19%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
420.8
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
420.7
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
3,578.96%
|
-
|
-
|
-
|
EPS
2 |
-
|
-1.310
|
-2.130
|
-2.260
|
1.430
|
-
|
-1.010
|
-0.8300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/03/21
|
30/08/21
|
28/03/22
|
24/08/22
|
30/03/23
|
24/08/23
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
24.4
|
Net Cash position
1 |
-
|
4,460
|
2,489
|
380
|
-
|
687
|
757
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.0665
x
|
Free Cash Flow
1 |
-
|
-956
|
-809
|
-
|
-
|
-1,214
|
-317
|
-229
|
ROE (net income / shareholders' equity)
|
-
|
-189%
|
-15.8%
|
-4.28%
|
-
|
-14%
|
-5.94%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-118%
|
-14.3%
|
-3.73%
|
-
|
-16.5%
|
-6.7%
|
-
|
Assets
1 |
-
|
4,807
|
7,061
|
6,631
|
-
|
3,779
|
2,247
|
-
|
Book Value Per Share
2 |
-
|
80.20
|
20.10
|
19.00
|
-
|
12.30
|
12.00
|
-
|
Cash Flow per Share
2 |
-
|
-5.530
|
-2.490
|
-3.880
|
-
|
-2.660
|
-0.6100
|
-
|
Capex
1 |
-
|
485
|
79
|
356
|
-
|
450
|
200
|
200
|
Capex / Sales
|
-
|
-
|
1,46,277.78%
|
2,780.59%
|
-
|
66.84%
|
13.14%
|
8.27%
|
Announcement Date
|
20/09/20
|
22/03/21
|
28/03/22
|
30/03/23
|
27/03/24
|
-
|
-
|
-
|
Last Close Price
22.06
CNY Average target price
25.92
CNY Spread / Average Target +17.49% Consensus |
1st Jan change
|
Capi.
|
---|
| +16.99% | 975M | | -3.45% | 87.17B | | +1.97% | 40.1B | | +57.98% | 25.12B | | -14.82% | 15.59B | | -8.82% | 12B | | -16.29% | 11.8B | | -41.58% | 11.8B | | +6.89% | 8.81B | | -10.53% | 8.24B |
Biopharmaceuticals
|